Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-05 Equity Swap | 2024-04-08 4:14 pm | N/A N/A | NGM BIOPHARMACEUTICALS INC | NGM | Perlich Irene Principal Accounting Officer | 6,284 | $0 | 0 (Direct) | View |
| 2024-04-05 Disposition | 2024-04-08 4:14 pm | N/A N/A | NGM BIOPHARMACEUTICALS INC | NGM | Perlich Irene Principal Accounting Officer | 160,000 | $0 | 0 (Direct) | View |
| 2024-01-16 Tax Withholding | 2024-01-18 6:02 pm | N/A N/A | NGM BIOPHARMACEUTICALS INC | NGM | Perlich Irene PRINCIPAL ACCOUNTING OFFICER | 1,025 | $1.34 | 8,975 (Direct) | View |
| 2023-11-06 Option Award | 2023-11-08 6:11 pm | N/A 2031-03-31 | NGM BIOPHARMACEUTICALS INC | NGM | Perlich Irene Principal Accounting Officer | 102,500 | $0 | 102,500 (Direct) | View |
| 2023-11-06 Disposition | 2023-11-08 6:11 pm | N/A 2031-03-31 | NGM BIOPHARMACEUTICALS INC | NGM | Perlich Irene Principal Accounting Officer | 102,500 | $0 | 102,500 (Direct) | View |
Ownership | 2023-09-18 5:45 pm | N/A N/A | NGM BIOPHARMACEUTICALS INC | NGM | Perlich Irene Principal Accounting Officer | 0 | $0 | 142,500 (Direct) | View |